ALB vs LYSDY: How Albemarle and Lynas Rare Earths Compare (2026)

Same yardstick, side by side (as of July 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: ALB is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ALB and LYSDY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ALB and LYSDY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Albemarle (ALB) is one of the world's largest producers of lithium, a critical input for the batteries that power electric vehicles, consumer electronics, and grid storage. Its Energy Storage segment mines and processes lithium from hard-rock and brine resources into battery-grade lithium hydroxide and carbonate sold to battery makers and automakers. Albemarle also runs a Specialties business (bromine-based flame retardants and other fine chemicals used in electronics, construction, and oilfield applications) and a catalysts business serving refining and petrochemical customers. The lithium segment drives most of the company's growth narrative and its share-price volatility, because lithium prices swing sharply with the supply-demand balance of the EV battery supply chain. Albemarle controls some of the lowest-cost and largest lithium resources in the world, including assets in Chile, Australia, and the United States. Founded in 1994 and headquartered in Charlotte, North Carolina, Albemarle is a cyclical specialty-chemicals company whose fortunes are tightly linked to electric vehicle adoption and lithium pricing.

Full ALB guide

Lynas Rare Earths is an Australian company that mines and processes rare earth elements, the metals used to make the permanent magnets inside electric-vehicle motors, wind turbines, defense systems, robotics, and many electronics. It mines rare earth concentrate at its Mt Weld deposit in Western Australia, one of the highest-grade rare earth deposits in the world, and refines it primarily at its Lynas Advanced Materials Plant (LAMP) in Kuantan, Malaysia, with a newer processing facility at Kalgoorlie in Western Australia. Its flagship product is separated NdPr (neodymium-praseodymium) oxide. China dominates global rare earth mining and processing (over roughly 80 to 90 percent of separation capacity), which makes Lynas strategically important as the largest scaled producer of separated rare earths outside China. Primary listing is on the ASX (ticker LYC); LYSDY is the US OTC ADR.

Full LYSDY guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ALB drivers: Lithium and EV demand; Low-cost resource position.
• LYSDY drivers: Western rare earth supply-chain independence; Heavy rare earth separation leadership.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Albemarle's earnings are extremely sensitive to lithium prices, which collapsed from their 2022 peak as supply caught up with demand and EV growth cooled, swinging the company from large profits toward losses. For LYSDY, rare earth prices, particularly NdPr, are volatile and heavily influenced by Chinese export and pricing policy, which can compress Lynas's realized prices and earnings independent of its own execution.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ALB if you believe its drivers more; LYSDY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ALB and LYSDY guides.

ALB. Albemarle is a commodity-linked specialty chemicals company, so traditional P/E framing is unreliable: earnings swing from large profits at peak lithium prices to losses in troughs. The market values it on the long-term lithium demand story and its low-cost resource base, with the share price highly sensitive to lithium spot prices and EV adoption sentiment rather than steady-state multiples.

LYSDY. Lynas trades far more on strategic and pricing narratives than on trailing earnings. Revenue is real and growing, but net profit has been thin because realized NdPr prices stayed weak into 2025, which is why trailing P/E screens as very high. The large cash balance funds heavy rare earth expansion, and figures are reported in Australian dollars, so approximate US-dollar equivalents shift with the exchange rate.

Headline figures (approximate, early 2026): ALB shows revenue (ttm) ~$5 billion (down sharply from the lithium-price peak), operating margin Volatile; thin or negative in lithium-price troughs, earnings Swings between profit and loss with lithium prices, dividend yield ~2-3%; LYSDY shows revenue (fy2025, ended june 2025) ~A$557 million (about US$365 million), revenue growth (fy2025) ~20 percent year over year, net profit (fy2025) ~A$8 million (down sharply from the prior year on soft NdPr prices), cash position ~A$1 billion following a ~A$930 million equity raise.

ALB and LYSDY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ALB and LYSDY exposure against your real portfolio. It is not an investment adviser.